Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CRL✓SelectedUSD · CRLGSK vs CRL performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs CRL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
CRL return
+327.6%
Excess return
-230.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCRLExcessAlpha
1D-0.1%-4.2%+4.0%+0.5%
7D-5.3%-7.0%+1.7%-4.3%
30D-3.7%-8.9%+5.2%-2.6%
3M-7.3%+7.8%-15.1%-9.0%
6M-4.2%+101.4%-105.7%-15.7%
YTD+0.9%+57.6%-56.7%-8.2%
1Y+7.3%+93.9%-86.7%-5.9%
3Y+52.7%+65.0%-12.2%+32.8%
5Y+40.1%-17.3%+57.4%+38.4%
All+97.1%+327.6%-230.6%+26.1%

Cumulative growth

Daily Returns

Daily percentage return beside CRL.

Daily Out/Under-Performance

Portfolio return minus CRL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CRL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CRL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling